Efficient Escherichia coli platform for L-proline biosynthesis via systematic metabolic engineering
Related Experiment Video
Updated: Oct 31, 2026

Inducible T7 RNA Polymerase-mediated Multigene Expression System, pMGX
Published on: June 27, 2017
Shumei Cui1, Xiaolu Hu1, Xinwei Yang2
1National and Local United Engineering Research Center of Industrial Microbiology and Fermentation Technology, Engineering Research Center of Industrial Microbiology of Ministry of Education, College of Life Sciences, Fujian Normal University, Fujian, People's Republic of China.
Abstract:
Despite its prominent industrial use for L-proline production, microbial fermentation by Corynebacterium glutamicum achieves a suboptimal yield of glucose conversion, far below the theoretical maximum of 0.63 g/g. This study aimed to develop an efficient engineered Escherichia coli chassis to produce L-proline from glucose by addressing the rate-limiting enzymatic step and high glucose conversion. The γ-glutamyl kinase encoding gene (proB) was screened by directed evolution, and the catalytic efficiency of the ScProB** variant toward L-glutamate increased 2.75-fold. After channeling 2-oxoglutarate flux and supplying sufficient NADPH, L-proline production reached 86.27 ± 2.58 g/L, with a 0.33 ± 0.01 g/g glucose yield in 10-L fed-batch fermentation. Further increasing the flux through central carbon metabolism by implementing a non-PTS glucose uptake system, amplifying the anaplerotic reaction, and redirecting the flux away from the glyoxylate cycle, the resulting strain BP23 achieved 119.89 ± 5.66 g/L L-proline, with a productivity of 1.93 ± 0.03 g/L/h. The glucose conversion yield improved to 0.49 ± 0.01 g/g after 62 h of fed-batch fermentation, indicating that the E. coli strain is a promising workhorse for producing L-proline with high glucose conversion.
More Related Videos
10:31Residue-Specific Exchange of Proline by Proline Analogs in Fluorescent Proteins: How "Molecular Surgery" of the Backbone Affects Folding and Stability
Published on: February 3, 2022
09:45Escherichia coli-Based Cell-Free Protein Synthesis: Protocols for a robust, flexible, and accessible platform technology
Published on: February 25, 2019
Related Concept Videos
Stringent Response in E. coli
Production of Pharmaceuticals